Information
-
Trademark
-
86685801
-
Serial Number
86685801
-
Registration Number
5025167
-
International Classifications
-
Filing Date
July 07, 2015
9 years ago
-
Registration Date
August 23, 2016
8 years ago
-
Transaction Date
April 18, 2023
a year ago
-
Status Date
March 10, 2023
2 years ago
-
Published for Opposition Date
June 07, 2016
8 years ago
-
Location Date
August 23, 2016
8 years ago
-
Status Code
710
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
CANTONE, KERI H
-
Attorney Docket Number
TM15-700
Attorney Name
KAUSHAL ODEDRA
Law Office Assigned Location Code
L40
-
Owners
Mark Drawing Code
4000
Mark Identification
COMPLEGENT
Case File Statements
- GS0051: Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, agents for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
Case File Event Statements
-
3/10/2023 - 2 years ago
27 - CANCELLED SEC. 8 (6-YR)
Type: C8..
-
8/23/2021 - 3 years ago
26 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
9/4/2019 - 5 years ago
25 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
8/23/2016 - 8 years ago
24 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/7/2016 - 8 years ago
23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/7/2016 - 8 years ago
22 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/18/2016 - 8 years ago
21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/2/2016 - 8 years ago
20 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
4/22/2016 - 8 years ago
19 - ASSIGNED TO LIE
Type: ALIE
-
4/11/2016 - 8 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
3/16/2016 - 8 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
3/16/2016 - 8 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/16/2016 - 8 years ago
15 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/20/2015 - 9 years ago
14 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
3/9/2016 - 9 years ago
13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
10/22/2015 - 9 years ago
12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
10/22/2015 - 9 years ago
11 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
10/22/2015 - 9 years ago
10 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
10/15/2015 - 9 years ago
9 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/20/2015 - 9 years ago
8 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Type: AMPX
-
8/5/2015 - 9 years ago
7 - LEGAL INSTRUMENT EXAMINER (LIE) - CORRECTION
Type: LIEC
-
8/5/2015 - 9 years ago
6 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
8/5/2015 - 9 years ago
5 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/29/2015 - 9 years ago
4 - ASSIGNED TO LIE
Type: ALIE
-
7/20/2015 - 9 years ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
7/10/2015 - 9 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
7/10/2015 - 9 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP